Consolidated Statements of Changes in Stockholders’ Equity (Deficit) / Members’ Equity (Deficit) - USD ($) $ in Thousands	Total	Private Placement	Public Offering	Common Stock and Class B Common Stock	Preferred Stock	Preferred Stock Private Placement	Treasury Stock	Additional paid-in capital	Additional paid-in capital Private Placement	Additional paid-in capital Public Offering	Retained earnings (Accumulated deficit)	Accumulated other comprehensive income (loss)	Noncontrolling interests in subsidiaries	Common Stock	Common Stock Common Stock and Class B Common Stock	Common Stock Common Stock and Class B Common Stock Private Placement	Common Stock Common Stock and Class B Common Stock Public Offering	Class B Common Stock Common Stock and Class B Common Stock	Series C-1 Preferred Stock	Series C-1 Preferred Stock Preferred Stock	Series C-1 Preferred Stock Additional paid-in capital
Common Stock, beginning balance (in shares) at Dec. 31, 2019															40,816,000			31,564,000
Preferred Stock, beginning balance (in shares) at Dec. 31, 2019					0
Treasury Stock, beginning balance (in shares) at Dec. 31, 2019							0
Balance at beginning of period at Dec. 31, 2019	$ (65,783)				$ 0		$ 0	$ 0			$ (40,258)	$ 1,431	$ (26,963)		$ 4			$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for acquisitions (in shares)															5,927,000
Issuance of stock for acquisitions	$ 123,887							123,886							$ 1
Exchange of Class B Common Stock for Class A Common Stock (in shares)	18,167,547														16,660,000			(16,660,000)
Exchange of Class B Common Stock for Class A Common Stock								(35,271)					35,271		$ 2			$ (2)
Exchange of Class B Common Stock for cash (in shares)																		(1,508,000)
Exchange of Class B Common Stock for cash	$ (44,273)												(44,273)
Forfeiture of Class B Common Stock (in shares)																		(177,000)
Exercise of warrants (in shares)	881,239														4,105,000
Exercise of warrants	$ 24,495							24,494							$ 1
Reclassification of warrant liability to equity for exercised warrants	49,098							49,098
Equity-based compensation (in shares)															635,000
Equity-based compensation	$ 18,670							18,670
Exchange of Class A Common Stock for Series B-1 Preferred Stock (in shares)					158,000										(15,810,000)
Exchange of Class A Common Stock for Series B-1 Preferred Stock					$ 1			1							$ (2)
Sale of stock, net of offering costs (in shares)						75,000										10,930,000	9,200,000
Sale of stock, net of offering costs		$ 223,361	$ 132,514						$ 223,360	$ 132,513						$ 1	$ 1
Conversion of Series B-2 Preferred Stock to Series B-1 Preferred Stock (in shares)					(9,000)
Conversion of Series A Preferred Stock to Class A Common Stock (in shares)					(40,000)										2,888,000
Conversion of Series B-1 Preferred Stock to Class A Common Stock (in shares)					(20,000)									2,000,000	2,000,000
Issuance of Common Stock in connection with Contingent Consideration Shares (in shares)	1,000,000														1,000,000
Issuance of Common Stock in connection with Contingent Consideration Common Shares	$ 37,556							37,556
Distributions to noncontrolling interests	(800)												(800)
Common Stock issued in connection with employee stock purchase plan (in shares)															6,000
Common Stock issued in connection with employee stock purchase plan	101							101
Net income (loss)	(194,086)										(161,632)		(32,454)
Equity activity resulting from Tax Receivable Agreement	24,787							24,787
Equity activity resulting from other increases in AdaptHealth Corp.'s ownership in AdaptHealth Holdings	(8,088)							(8,088)
Equity impact resulting from the Put/Call Agreement (in shares)															(1,899,000)
Equity impact resulting from the Put/Call Agreement	(29,927)							(32,621)			2,694
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	(10,667)											(5,842)	(4,825)
Common Stock, ending balance (in shares) at Dec. 31, 2020															76,458,000			13,219,000
Preferred Stock, ending balance (in shares) at Dec. 31, 2020					164,000
Treasury Stock, ending balance (in shares) at Dec. 31, 2020							0
Balance at end of period at Dec. 31, 2020	280,845				$ 1		$ 0	558,486			(199,196)	(4,411)	(74,044)		$ 8			$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Offering costs	11,725	$ 1,639	10,086
Issuance of stock for acquisitions (in shares)															15,725,000					130,000
Issuance of stock for acquisitions	602,661							602,659							$ 2				$ 523,856		$ 523,856
Issuance of stock options for acquisitions	$ 134,683							134,683
Exchange of Class B Common Stock for Class A Common Stock (in shares)	13,218,758														13,219,000			(13,219,000)
Exchange of Class B Common Stock for Class A Common Stock	$ 77,900							(74,200)				(3,719)	77,919		$ 1			$ (1)
Exercise of warrants (in shares)															118,000
Reclassification of warrant liability to equity for exercised warrants	2,960							2,960
Equity-based compensation (in shares)															571,000
Equity-based compensation	$ 25,323							25,323
Exercise of stock options (in shares)	1,447,000														1,139,000
Exercise of options	$ 12,320							12,320
Cashless exercise of stock options (in shares)															133,000
Sale of stock, net of offering costs (in shares)																	8,450,000
Sale of stock, net of offering costs			265,018							$ 265,017							$ 1
Conversion of Series B-1 Preferred Stock to Class A Common Stock (in shares)					(40,000)									3,950,000	3,950,000
Conversion Of Series C-1 Preferred Stock to Class A Common Stock (in shares)					(130,000)										13,047,000
Conversion of Series C-1 Preferred Stock to Class A Common Stock								(1)							$ 1
Issuance of Common Stock in connection with Contingent Consideration Shares (in shares)	1,000,000														1,000,000
Issuance of Common Stock in connection with Contingent Consideration Common Shares	$ 41,088							41,088
Distributions to noncontrolling interests	(1,070)												(1,070)
Common Stock issued in connection with employee stock purchase plan (in shares)															34,000
Common Stock issued in connection with employee stock purchase plan	1,016							1,016
Net income (loss)	158,153										156,175		1,978
Equity activity resulting from Tax Receivable Agreement	17,617							17,617
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	5,776											5,776
Tax withholdings	$ (3,557)							(3,557)
Common Stock, ending balance (in shares) at Dec. 31, 2021	133,843,732														133,844,000			0
Preferred Stock, ending balance (in shares) at Dec. 31, 2021					124,000
Treasury Stock, ending balance (in shares) at Dec. 31, 2021							0
Balance at end of period at Dec. 31, 2021	$ 2,066,689				$ 1		$ 0	2,107,267			(43,021)	(2,354)	4,783		$ 13			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Offering costs	13,832		$ 13,832
Shares purchased under share repurchase program (in shares)				751,000			750,835
Shares purchased under share repurchase program	(13,992)						$ (13,992)
Reclassification of warrant liability to equity for exercised warrants (in shares)															88,000
Reclassification of warrant liability to equity for exercised warrants	2,103							2,103
Deferred tax impact relating to contingent consideration common shares	(1,603)							(1,603)
Equity-based compensation (in shares)															555,000
Equity-based compensation	$ 22,397							22,397
Exercise of stock options (in shares)	804,000														621,000
Exercise of options	$ 2,510							2,510
Conversion of Series B-1 Preferred Stock to Class A Common Stock (in shares)														0
Issuance of Common Stock in connection with Contingent Consideration Shares (in shares)	0
Distributions to noncontrolling interests	$ (2,000)												(2,000)
Common Stock issued in connection with employee stock purchase plan (in shares)															78,000
Common Stock issued in connection with employee stock purchase plan	1,616							1,616
Net income (loss)	73,133										69,316		3,817
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	11,047											11,047
Tax withholdings	$ (4,142)							(4,142)
Common Stock, ending balance (in shares) at Dec. 31, 2022	134,435,119														134,435,000			0
Preferred Stock, ending balance (in shares) at Dec. 31, 2022	124,060				124,000
Treasury Stock, ending balance (in shares) at Dec. 31, 2022	750,835						751,000
Balance at end of period at Dec. 31, 2022	$ 2,157,758				$ 1		$ (13,992)	$ 2,130,148			$ 26,295	$ 8,693	$ 6,600		$ 13			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Offering costs	$ 0